New radiation attack on chest tumors shows promise
NCT ID NCT06603987
First seen Nov 19, 2025 · Last updated May 14, 2026 · Updated 24 times
Summary
This early-phase trial tests a targeted radiation therapy called BNCT for people with recurrent chest tumors that cannot be surgically removed and have not responded to standard treatments. About 30 participants will receive a boron-based drug followed by neutron radiation to destroy cancer cells while sparing healthy organs. The study aims to check safety and whether the treatment can control tumor growth.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THORACIC SOLID MALIGNANT TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ORIX Kouraibashi Bldg. 8F 3-2-7 Kouraibashi Chuo-ku
Osaka, Osaka, 541-0043, Japan
Conditions
Explore the condition pages connected to this study.